Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

J&J signs $1.1bn deal with Genmab for cancer antibody

Licenses daratumumab in development for multiple myeloma

AstraZeneca taps social media for employee wellness drive

Interactive ‘Shape Up’ website offers staff chance to track their health and fitness

- PMLiVE

Bayer files regorafenib for GIST in US

Follows priority review for drug in metastatic colorectal cancer

- PMLiVE

FDA approves Teva’s biosimilar for neutropaenia in cancer patients

Neupogen biosimilar already marketed in Europe as Tevagrastim

- PMLiVE

Galectin Therapuetics appoints Harold Shlevin as chief operating officer

Will replace company co-founder Maureen Foley

Publicis to Merge Razorfish and Healthware International

Publicis is to merge its two digital agencies, Razorfish and Publicis Healthware International. The new enterprise will be called Razorfish Healthware as of immediate effect

- PMLiVE

Abbott’s Humira receives expanded Crohn’s disease indication in Europe

Also receives FDA panel backing in ulcerative colitis

Lilly drops touted Zyprexa successor for use in schizophrenia

Pomaglumetad methionil disappoints in phase III

UK doctors to be offered ‘highway code’ for social media

RCGP will later this year launch new guidelines to help GPs use sites like Twitter and Facebook appropriately

Novartis building

Novartis on track to file COPD drug in Europe by year-end

Will also file QVA149 in Japan after positive phase III trial results

- PMLiVE

Zaicom appoints John Storey as research director

Joins from YouGov to integrate research efforts with regulatory and marketing teams

- PMLiVE

Roche’s Avastin remains most requested drug in UK’s cancer drugs fund

Accounts for nearly a quarter of all applications

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links